Welcome to the e-CCO Library Archive!

Filter:
P230. Influence of stress in the clinical course of inflammatory bowel disease patients
Authors:

M. Iglesias-Rey1, M. Barreiro-de Acosta1, R. Ferreiro1, F. Caamaño2, I. Vazquez3, A. Lorenzo1, J.E. Dominguez-Munoz1, 1University Hospital, Gastroenterology, Santiago, Spain, 2University Hospital, Epidemiology, Santiago, Spain, 3Univesity of Santiago, Psychology, Santiago, Spain

P230. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
P230

ECCO endoscopy consensus for Inflammatory Bowel Disease and daily clinical practice: A need for dedicated training

Authors:

L. Roque Ramos*, T. Meira, R. Barosa, P. Figueiredo, A. Vieira, J. Freitas

Hospital Garcia de Orta, Gastroenterology, Almada, Portugal

P231.

Early onset inflammatory bowel disease: phenotype and burden of disease. Experience at Cambridge University Hospitals – United Kingdom

Authors:

M. Gasparetto1, G. Guariso2, F. Torrente1, M. Brennan3, R. Heuschkel1, M. Zilbauer1, 1Addenbrooke's – Cambridge University Hospitals NHS, Children's Services – Paediatric Gastroenterology Unit, Cambridge, United Kingdom, 2University Hospital of Padua, Women and Children's Health, Paediatric Gastroenterology Unit, Padova, Italy, 3Addenbrooke's – Cambridge University Hospitals NHS, Children' Services – Paediatric Gastroenterology Unit, Cambridge, United Kingdom

P231. Efficacy of hepatitis B vaccination and re-vaccination and factors impacting on the response in inflammatory bowel disease patients
P231. Hypovitaminosis D in inflammatory bowel disease patients: Is there association with quality of life and disease activity?
Authors:

I.A. Pintilie1, G. Dumitrescu1, M. Dranga1, E. Toader2, C. Cijevschi Prelipcean2, 1Sf. Spiridon Hospital, Gastroenterology and Hepatology, Iasi, Romania, 2University of Medicine and Pharmacy Gr. T. Popa, Gastroneterology and Hepatology, Iasi, Romania

P231. No association between vedolizumab exposure and serum JC virus levels
P231

Diagnostic delay is associated with higher rate of major surgery in a French prospective cohort of patients with Crohn's Disease

Authors:

S. Nahon1, T. Paupard2, P. Lahmek3, B. Lesgourgues1, S. Chaussade4, L. Peyrin-Biroulet5, V. Abitbol*4

1Centre Hospitalier Le Raincy, Gastroenterology, Montfermeil, France, 2Centre hospitalier Dunkerque, Division of Gastroenterology and Hepatology, Dunkerque, France, 3Hôpital Emile Roux, Gastroenterology Addictology, Limeil-Brevannes, France, 4Hôpital Cochin, Gastroenterology, Paris, France, 5University and Hospital, Gastroenterology, Nancy, France

P232.

Evaluation of the use of fecal calprotectin as a diagnostic aid for IBD in an Irish population

Authors:

P. Maheshwari1, P. Junagade2, C. Goulding1, 1Galway, Gastroenterology, Galway, Ireland, 2Limerick, Gastroenterology, Limerick, Ireland

P232. Adalimumab in steroid-dependent Crohn's disease patients: Analysis of efficacy, prognostic factors for clinical benefit and safety
P232. How frequent is gastrointestinal tuberculosis in patients with ileocecal inflammation in a tuberculosis prevelant country: Evaluation of 114 consecutive patients in an inflammatory bowel disease clinic of a tertiary referral center
Authors:

Y. Erzin1, I. Hatemi1, G. Aygun2, S. Erdamar3, A.F. Celik1, 1Istanbul University Cerrahpasa Medical Faculty, Gastroenterology, Istanbul, Turkey, 2Istanbul University Cerrahpasa Medical faculty, Microbiology, Istanbul, Turkey, 3Istanbul University Cerrahpasa Medical Faculty, Pathology, Turkey

P232. Shorter infliximab administration infusion times in Crohn's disease are safe and well tolerated
P232

Real-time Shear Wave Ultrasound Elastography in distinguishing inflammatory from fibrotic stenosis in Crohn's disease

Authors:

Y.-j. Chen*1, R. Mao2, Y. He2, B.-l. Chen2, Z.-r. Zeng2, X.-y. Xie1, M.-h. Chen2

1First Affiliated Hospital of Sun Yat-sen University, Department of Medical Ultrasonics, Guangzhou, China, 2First Affiliated Hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China

P233.

Early measurement of fecal calprotectin after intestinal resection is useful to predict postoperative recurrence in patients with Crohn's disease

Authors:

M. Laidet1, G. Boschetti1, G. Phelip1, A.-L. Charlois1, C. Menard1, J. Drai2, B. Flourié1, S. Nancey1, 1Hospices Civils de Lyon, Lyon-Sud hospital, Gastroenterology, Pierre Benite, France, 2Hospices Civils de Lyon, Lyon-Sud hospital, Biochemistry, Pierre-Benite, France

P233. Adalimumab produces high responder and remission rates and has an independent effect on quality of life in Crohn's disease patients
P233. Comparative study to evaluate the effectiveness of two different vaccination protocols against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients
P233. How accurate are capsule endoscopy scoring systems in Crohn's disease?
Authors:

G. Holleran1,2, B. Hall1,2, M. Hussey2, O. Thornton2, M. Dobson2, D. McNamara1,2, 1Trinity College Dublin, Clinical Medicine, Dublin, Ireland, 2AMNCH, Department of Gastroenterology, Dublin, Ireland

P233

Risk factors and clinical signicance of endoscopic entent progression in patients with Ulcerative Colitis

Authors:

Y.-f. Li1, R. Mao*2, B.-l. Chen2, Y. He2, Z.-r. Zeng2, M.-h. Chen2

1Singapore General Hospital, Department of Internal Medicine, Singapore, Singapore, 2First Affiliated Hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China

P234.

Double balloon endoscopy and Crohn's disease: Does it still work?

Authors:

S. Hulagu, G. Sirin, O. Senturk, A. Celebi, Kocaeli University, Gastroenterology, Kocaeli, Turkey

P234. High risk of leaving the workforce in US employees with ulcerative colitis
Authors:

R.D. Cohen1, J. Rizzo2, M. Yang2, M. Skup2, D. Macaulay3, C. Behrer3, B. Fok3, P.M. Mulani2, J. Chao2, 1University of Chicago, Chicago, IL, United States, 2Abbott Laboratories, Abbott Park, IL, United States, 3Analysis Group, Inc., New York, NY, United States